Hyperhomocysteinemia selectively alters expression and stoichiometry of intermediate filament and induces glutamate- and calcium-mediated mechanisms in rat brain during development

International Journal of Developmental Neuroscience

Volumn 28, Issue 1, 2010, Pages 21-30

  Loureiro, Samanta Oliveira ^a   Heimfarth, Luana ^a   Pelaez, Priscila de Lima ^a   Lacerda, Bruna Arcce ^a   Vidal, Luiza Fedatto ^a   Soska, Angela ^a   Santos, Natália Gomes dos ^a   Andrade, Cláudia ^a   Tagliari, Bárbara ^a   Scherer, Emilene B S ^a   Guma, Fátima Therezinha Costa Rodrigues ^a   Wyse, Angela Terezinha de Souza ^a   Pessoa Pureur, Regina ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Calcium; Glutamate receptors; Homocysteine; Hyperhomocysteinemia; Intermediate filaments; Phosphatases

Indexed keywords

CALCINEURIN; CALCIUM ION; GLIAL FIBRILLARY ACIDIC PROTEIN; IONOTROPIC RECEPTOR; METABOTROPIC RECEPTOR; NEUROFILAMENT H PROTEIN; NEUROFILAMENT L PROTEIN; NEUROFILAMENT M PROTEIN; NEUROFILAMENT PROTEIN; PHOSPHOPROTEIN PHOSPHATASE 1; PHOSPHOPROTEIN PHOSPHATASE 2A; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN DAMAGE; BRAIN DEVELOPMENT; CALCIUM TRANSPORT; CONTROLLED STUDY; HIPPOCAMPUS; HYPERHOMOCYSTEINEMIA; IN VITRO STUDY; IN VIVO STUDY; INTERMEDIATE FILAMENT; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SIGNAL TRANSDUCTION; STOICHIOMETRY;

AGING; ANIMALS; BRAIN; CALCIUM; CEREBRAL CORTEX; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; GLUTAMIC ACID; HIPPOCAMPUS; HYPERHOMOCYSTEINEMIA; INTERMEDIATE FILAMENT PROTEINS; INTERMEDIATE FILAMENTS; PHOSPHORYLATION; RATS; RATS, WISTAR; RECEPTORS, GLUTAMATE; RECEPTORS, METABOTROPIC GLUTAMATE; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL;

ANIMALIA; RATTUS;

EID: 74449090061     PISSN: 07365748     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijdevneu.2009.10.002     Document Type: Article

References (91)

1. Alam Z., Coombes N., Waring R.H., Williams A.C., and Steventon G.B. Plasma levels of neuroexcitatory amino acids in patients with migraine or tension headache. J. Neurol. Sci. 156 (1998) 102-106
2. Alberts B., Johnson A., Lewis J., Raff M., Roberts K., and Walter P. Mechanisms of cell communication. Molecular Biology of the Cell (2008), Garland Sciences, Abingdon, UK pp. 879-964
3. Algaidi S.A., Christie L.A., Jenkinson A.M., Whalley L., Riedel G., and Platt B. Long-term homocysteine exposure induces alterations in spatial learning, hippocampal signalling and synaptic plasticity. Exp. Neurol. 197 (2006) 8-21
4. Bachetti T., Caroli F., Bocca P., Prigione I., Balbi P., Biancheri R., Filocamo M., Mariotti C., Pareyson D., Ravazzolo R., and Ceccherini I. Mild functional effects of a novel GFAP mutant allele identified in a familial case of adult-onset Alexander disease. Eur. J. Hum. Genet. 16 (2008) 462-470
5. Baydas G., Koz S.T., Tuzcu M., Nedzvetsky V.S., and Etem E. Effects of maternal hyperhomocysteinemia induced by high methionine diet on the learning and memory performance in offspring. Int. J. Dev. Neurosci. 25 (2007) 133-139
6. Beaulieu J.M., Nguyen M.D., and Julien J.P. Late onset of motor neurons in mice overexpressing wild-type peripherin. J. Cell Biol. 147 (1999) 531-544
7. Bjornar Hassel R.D. Glutamate. Basic Neurochemistry (2006), Elsevier Academic Press, London pp. 267-290
8. Boldyrev A.A., and Johnson P. Homocysteine and its derivatives as possible modulators of neuronal and non-neuronal cell glutamate receptors in Alzheimer's disease. J. Alzheimer's Dis. 11 (2007) 219-228
9. Chang L., and Goldman R.D. Intermediate filaments mediate cytoskeletal crosstalk. Nat. Rev.Mol. Cell Biol. 5 (2004) 601-613
10. Coulombe P.A., Ma L., Yamada S., and Wawersik M. Intermediate filaments at a glance. J. Cell Sci. 114 (2001) 4345-4347
11. Danzer S.C. Postnatal and adult neurogenesis in the development of human disease. Neuroscientist 14 (2008) 446-458
12. Feng J., Yan Z., Ferreira A., Tomizawa K., Liauw J.A., Zhuo M., Allen P.B., Ouimet C.C., and Greengard P. Spinophilin regulates the formation and function of dendritic spines. Proc. Natl. Acad. Sci. Online (US) 97 (2000) 9287-9292
13. Ferlazzo N., Condello S., Curro M., Parisi G., Ientile R., and Caccamo D. NF-kappaB activation is associated with homocysteine-induced injury in Neuro2a cells. BMC Neurosci. 9 (2008) 62
14. Fiumelli H., Riederer I.M., Martin J.L., and Riederer B.M. Phosphorylation of neurofilament subunit NF-M is regulated by activation of NMDA receptors and modulates cytoskeleton stability and neuronal shape. Cell Motil. Cytoskel. 65 (2008) 495-504
15. Fuchs E., and Cleveland D.W. A structural scaffolding of intermediate filaments in health and disease. Science 279 (1998) 514-519
16. Funchal C., de Almeida L.M., Oliveira Loureiro S., Vivian L., de Lima Pelaez P., Dall Bello Pessutto F., Rosa A.M., Wajner M., and Pessoa-Pureur R. In vitro phosphorylation of cytoskeletal proteins from cerebral cortex of rats. Brain Res. Protocols 11 (2003) 111-118
17. Ge W.W., Leystra-Lantz C., Wen W., and Strong M.J. Selective loss of trans-acting instability determinants of neurofilament mRNA in amyotrophic lateral sclerosis spinal cord. J. Biol. Chem. 278 (2003) 26558-26563
18. Grant P., and Pant H.C. Neurofilament protein synthesis and phosphorylation. J. Neurocytol. 29 (2000) 843-872
19. Helfand B.T., Chang L., and Goldman R.D. Intermediate filaments are dynamic and motile elements of cellular architecture. J. Cell Sci. 117 (2004) 133-141
20. Herrmann H., and Aebi U. Intermediate filaments: molecular structure, assembly mechanism, and integration into functionally distinct intracellular Scaffolds. Annu. Rev. Biochem. 73 (2004) 749-789
21. Ho P.I., Ashline D., Dhitavat S., Ortiz D., Collins S.C., Shea T.B., and Rogers E. Folate deprivation induces neurodegeneration: roles of oxidative stress and increased homocysteine. Neurobiol. Dis. 14 (2003) 32-42
22. Ho P.I., Ortiz D., Rogers E., and Shea T.B. Multiple aspects of homocysteine neurotoxicity: glutamate excitotoxicity, kinase hyperactivation and DNA damage. J. Neurosci. Res. 70 (2002) 694-702
23. Janosch P., Kieser A., Eulitz M., Lovric J., Sauer G., Reichert M., Gounari F., Buscher D., Baccarini M., Mischak H., and Kolch W. The Raf-1 kinase associates with vimentin kinases and regulates the structure of vimentin filaments. FASEBJ J. 14 (2000) 2008-2021
24. Jones S.M., and Williams Jr. R.C. Phosphate content of mammalian neurofilaments. J. Biol. Chem. 257 (1982) 9902-9905
25. Julien J.P. Amyotrophic lateral sclerosis: unfolding the toxicity of the misfolded. Cell 104 (2001) 581-591
26. Julien J.P., and Beaulieu J.M. Cytoskeletal abnormalities in amyotrophic lateral sclerosis: beneficial or detrimental effects?. J. Neurol. Sci. 180 (2000) 7-14
27. Julien J.P., and Mushynski W.E. Multiple phosphorylation sites in mammalian neurofilament polypeptides. J. Biol. Chem. 257 (1982) 10467-10470
28. Kim J.H., Cho S.Y., Lee J.H., Jeong S.M., Yoon I.S., Lee B.H., Pyo M.K., Lee S.M., Chung J.M., Kim S., Rhim H., Oh J.W., and Nah S.Y. Neuroprotective effects of ginsenoside Rg3 against homocysteine-induced excitotoxicity in rat hippocampus. Brain Res. 1136 (2007) 190-199
29. Kraus J.P. Biochemistry and molecular genetics of cystathionine beta-synthase deficiency. Eur. J. Pediatr. 157 Suppl. 2 (1998) S50-53
30. Kruman I.I., Culmsee C., Chan S.L., Kruman Y., Guo Z., Penix L., and Mattson M.P. Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity. J. Neurosci. 20 (2000) 6920-6926
31. Ksiezak-Reding H., and Yen S.H. Phosphatase and carbocyanine dye binding define different types of phosphate groups in mammalian neurofilaments. J. Neurosci. 7 (1987) 3554-3560
32. Kuhn W., Roebroek R., Blom H., van Oppenraaij D., Przuntek H., Kretschmer A., Buttner T., Woitalla D., and Muller T. Elevated plasma levels of homocysteine in Parkinson's disease. Eur. Neurol. 40 (1998) 225-227
33. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
34. Langmeier M., Folbergrova J., Haugvicova R., Pokorny J., and Mares P. Neuronal cell death in hippocampus induced by homocysteic acid in immature rats. Epilepsia 44 (2003) 299-304
35. Lariviere R.C., and Julien J.P. Functions of intermediate filaments in neuronal development and disease. J. Neurobiol. 58 (2004) 131-148
36. Lazarewicz J.W., Ziembowicz A., Matyja E., Stafiej A., and Zieminska E. Homocysteine-evoked 45Ca release in the rabbit hippocampus is mediated by both NMDA and group I metabotropic glutamate receptors: in vivo microdialysis study. Neurochem. Res. 28 (2003) 259-269
37. Leblhuber F., Walli J., Artner-Dworzak E., Vrecko K., Widner B., Reibnegger G., and Fuchs D. Hyperhomocysteinemia in dementia. J. Neural Transm. 107 (2000) 1469-1474
38. Lee H.Y., Chae I.H., Kim H.S., Park Y.B., Choi Y.S., Lee Y.W., Park S.J., and Cha Y.J. Differential effects of homocysteine on porcine endothelial and vascular smooth muscle cells. J. Cardiovasc. Pharmacol. 39 (2002) 643-651
39. Lee M.K., Xu Z., Wong P.C., and Cleveland D.W. Neurofilaments are obligate heteropolymers in vivo. J. Cell Biol. 122 (1993) 1337-1350
40. Lipton S.A., Kim W.K., Choi Y.B., Kumar S., D'Emilia D.M., Rayudu P.V., Arnelle D.R., and Stamler J.S. Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor. Proc. Natl. Acad. Sci. Online (US) 94 (1997) 5923-5928
41. Liu R., Zhou X.W., Tanila H., Bjorkdahl C., Wang J.Z., Guan Z.Z., Cao Y., Gustafsson J.A., Winblad B., and Pei J.J. Phosphorylated PP2A (tyrosine 307) is associated with Alzheimer neurofibrillary pathology. J. Cell. Mol. Med. 12 (2008) 241-257
42. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25 (2001) 402-408
43. Loureiro S.O., Heimfarth L., Pelaez Pde L., Vanzin C.S., Viana L., Wyse A.T., and Pessoa-Pureur R. Homocysteine activates calcium-mediated cell signaling mechanisms targeting the cytoskeleton in rat hippocampus. Int. J. Dev. Neurosci. 26 (2008) 447-455
44. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
45. Luchowska E., Luchowski P., Paczek R., Ziembowicz A., Kocki T., Turski W.A., Wielosz M., Lazarewicz J., and Urbanska E.M. Dual effect of DL-homocysteine and S-adenosylhomocysteine on brain synthesis of the glutamate receptor antagonist, kynurenic acid. J. Neurosci. Res. 79 (2005) 375-382
46. Luo Y., Zhou X., Yang X., and Wang J. Homocysteine induces tau hyperphosphorylation in rats. Neuroreport 18 (2007) 2005-2008
47. Makhro A.V., Mashkina A.P., Solenaya O.A., Trunova O.A., Kozina L.S., Arutyunian A.V., and Bulygina E.R. Prenatal hyperhomocysteinemia as a model of oxidative stress of the brain. Bull. Exp. Biol. Med. 146 (2008) 33-35
48. Malinow M.R. Hyperhomocyst(e)inemia. A common and easily reversible risk factor for occlusive atherosclerosis. Circulation 81 (1990) 2004-2006
49. Marx S.O., Reiken S., Hisamatsu Y., Jayaraman T., Burkhoff D., Rosemblit N., and Marks A.R. PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts. Cell 101 (2000) 365-376
50. Matte C., Monteiro S.C., Calcagnotto T., Bavaresco C.S., Netto C.A., and Wyse A.T. In vivo and in vitro effects of homocysteine on Na+, K+-ATPase activity in parietal, prefrontal and cingulate cortex of young rats. Int. J. Dev. Neurosci. 22 (2004) 185-190
51. Matte C., Scherer E.B., Stefanello F.M., Barschak A.G., Vargas C.R., Netto C.A., and Wyse A.T. Concurrent folate treatment prevents Na+, K+-ATPase activity inhibition and memory impairments caused by chronic hyperhomocysteinemia during rat development. Int. J. Dev. Neurosci. 25 (2007) 545-552
52. McEwen B.S. Plasticity of the hippocampus: adaptation to chronic stress and allostatic load. Ann. N.Y. Acad. Sci. 933 (2001) 265-277
53. Mignot C., Delarasse C., Escaich S., Della Gaspera B., Noe E., Colucci-Guyon E., Babinet C., Pekny M., Vicart P., Boespflug-Tanguy O., Dautigny A., Rodriguez D., and Pham-Dinh D. Dynamics of mutated GFAP aggregates revealed by real-time imaging of an astrocyte model of Alexander disease. Exp. Cell Res. 313 (2007) 2766-2779
54. Mudd S.H., Levy H.L., and Skovby F. Disorders of transulfuration. The Metabolic Basis of Inherited Disease (2001), McGraw-Hill, New York pp. 1279-1327
55. Muehlschlegel S., and Sims J.R. Dantrolene: mechanisms of neuroprotection and possible clinical applications in the neurointensive care unit. Neurocrit. Care 10 (2009) 103-115
56. Nixon R.A., and Lewis S.E. Differential turnover of phosphate groups on neurofilament subunits in mammalian neurons in vivo. J. Biol. Chem. 261 (1986) 16298-16301
57. Nixon R.A., and Sihag R.K. Neurofilament phosphorylation: a new look at regulation and function. Trends Neurosci. 14 (1991) 501-506
58. Omary M.B., Ku N.O., Tao G.Z., Toivola D.M., and Liao J. Heads and tails" of intermediate filament phosphorylation: multiple sites and functional insights. Trends Biochem. Sci. 31 (2006) 383-394
59. Panganamala R.V., Karpen C.W., and Merola A.J. Peroxide mediated effects of homocysteine on arterial prostacyclin synthesis. Prostaglandins Leukotr. Med. 22 (1986) 349-356
60. Pei J.J., Grundke-Iqbal I., Iqbal K., Bogdanovic N., Winblad B., and Cowburn R.F. Elevated protein levels of protein phosphatases PP-2A and PP-2B in astrocytes of Alzheimer's disease temporal cortex. J. Neural Transm. 104 (1997) 1329-1338
61. Petzold A. Neurofilament phosphoforms: surrogate markers for axonal injury, degeneration and loss. J. Neurolog. Sci. 233 (2005) 183-198
62. Peuchen S., Clark J.B., and Duchen M.R. Mechanisms of intracellular calcium regulation in adult astrocytes. Neuroscience 71 (1996) 871-883
63. Robert K., Pages C., Ledru A., Delabar J., Caboche J., and Janel N. Regulation of extracellular signal-regulated kinase by homocysteine in hippocampus. Neuroscience 133 (2005) 925-935
64. Saito T., Shima H., Osawa Y., Nagao M., Hemmings B.A., Kishimoto T., and Hisanaga S. Neurofilament-associated protein phosphatase 2A: its possible role in preserving neurofilaments in filamentous states. Biochemistry 34 (1995) 7376-7384
65. Selvakumar P., and Sharma R.K. Phosphorylation and dephosphorylation of human myristoyltransferase type 1. Can. J. Physiol. Pharmacol. 84 (2006) 707-712
66. Seshadri S., Beiser A., Selhub J., Jacques P.F., Rosenberg I.H., D'Agostino R.B., Wilson P.W., and Wolf P.A. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N. Engl. J. Med. 346 (2002) 476-483
67. Shi Q., Savage J.E., Hufeisen S.J., Rauser L., Grajkowska E., Ernsberger P., Wroblewski J.T., Nadeau J.H., and Roth B.L. L-homocysteine sulfinic acid and other acidic homocysteine derivatives are potent and selective metabotropic glutamate receptor agonists. J. Pharmacol. Exp. Ther. 305 (2003) 131-142
68. Shibasaki F., Hallin U., and Uchino H. Calcineurin as a multifunctional regulator. J. Biochem. 131 (2002) 1-15
69. Siebzehnrubl F.A., and Blumcke I. Neurogenesis in the human hippocampus and its relevance to temporal lobe epilepsies. Epilepsia 49 Suppl. 5 (2008) 55-65
70. Sihag R.K., Inagaki M., Yamaguchi T., Shea T.B., and Pant H.C. Role of phosphorylation on the structural dynamics and function of types III and IV intermediate filaments. Exp. Cell Res. 313 (2007) 2098-2109
71. Sontag E., Nunbhakdi-Craig V., Sontag J.M., Diaz-Arrastia R., Ogris E., Dayal S., Lentz S.R., Arning E., and Bottiglieri T. Protein phosphatase 2A methyltransferase links homocysteine metabolism with tau and amyloid precursor protein regulation. J. Neurosci. 27 (2007) 2751-2759
72. Stazka J., Luchowski P., and Urbanska E.M. Homocysteine, a risk factor for atherosclerosis, biphasically changes the endothelial production of kynurenic acid. Eur. J. Pharmacol. 517 (2005) 217-223
73. Strack S., Barban M.A., Wadzinski B.E., and Colbran R.J. Differential inactivation of postsynaptic density-associated and soluble Ca2+/calmodulin-dependent protein kinase II by protein phosphatases 1 and 2A. J. Neurochem. 68 (1997) 2119-2128
74. Strack S., Westphal R.S., Colbran R.J., Ebner F.F., and Wadzinski B.E. Protein serine/threonine phosphatase 1 and 2A associate with and dephosphorylate neurofilaments. Brain Res. Mol. Brain Res. 49 (1997) 15-28
75. Streck E.L., Delwing D., Tagliari B., Matte C., Wannmacher C.M., Wajner M., and Wyse A.T. Brain energy metabolism is compromised by the metabolites accumulating in homocystinuria. Neurochem. Int. 43 (2003) 597-602
76. Streck E.L., Feier G., Burigo M., Franzon R., Dal-Pizzol F., Quevedo J., and Wyse A.T. Effects of electroconvulsive seizures on Na(+), K(+)-ATPase activity in the rat hippocampus. Neurosci. Lett. 404 (2006) 254-257
77. Streck E.L., Matte C., Vieira P.S., Calcagnotto T., Wannmacher C.M., Wajner M., and Wyse A.T. Impairment of energy metabolism in hippocampus of rats subjected to chemically-induced hyperhomocysteinemia. Biochim. Biophys. Acta 1637 (2003) 187-192
78. Streck E.L., Matte C., Vieira P.S., Rombaldi F., Wannmacher C.M., Wajner M., and Wyse A.T. Reduction of Na(+), K(+)-ATPase activity in hippocampus of rats subjected to chemically induced hyperhomocysteinemia. Neurochem. Res. 27 (2002) 1593-1598
79. Streck E.L., Vieira P.S., Wannmacher C.M., Dutra-Filho C.S., Wajner M., and Wyse A.T. In vitro effect of homocysteine on some parameters of oxidative stress in rat hippocampus. Metab. Brain Dis. 18 (2003) 147-154
80. Streck E.L., Bavaresco C.S., Netto C.A., and Wyse A.T. Chronic hyperhomocysteinemia provokes a memory deficit in rats in the Morris water maze task. Behav. Brain. Res. 153 (2004) 377-381
81. Thyagarajan A., Strong M.J., and Szaro B.G. Post-transcriptional control of neurofilaments in development and disease. Exp. Cell Res. 313 (2007) 2088-2097
82. Watson D.F., Nachtman F.N., Kuncl R.W., and Griffin J.W. Altered neurofilament phosphorylation and beta tubulin isotypes in Charcot-Marie-Tooth disease type 1. Neurology 44 (1994) 2383-2387
83. Wyse A.T., Zugno A.I., Streck E.L., Matte C., Calcagnotto T., Wannmacher C.M., and Wajner M. Inhibition of Na(+), K(+)-ATPase activity in hippocampus of rats subjected to acute administration of homocysteine is prevented by vitamins E and C treatment. Neurochem. Res. 27 (2002) 1685-1689
84. Yoon S.Y., Choi H.I., Choi J.E., Sul C.A., Choi J.M., and Kim D.H. Methotrexate decreases PP2A methylation and increases tau phosphorylation in neuron. Biochem. Biophys. Res. Commun. 363 (2007) 811-816
85. Yoshimura Y., Sogawa Y., and Yamauchi T. Protein phosphatase 1 is involved in the dissociation of Ca2+/calmodulin-dependent protein kinase II from postsynaptic densities. FEBS Lett. 446 (1999) 239-242
86. Yuan A., Rao M.V., Sasaki T., Chen Y., Kumar A., Veeranna, Liem R.K., Eyer J., Peterson A.C., Julien J.P., and Nixon R.A. Alpha-internexin is structurally and functionally associated with the neurofilament triplet proteins in the mature CNS. J. Neurosci. 26 (2006) 10006-10019
87. Zhang C.E., Tian Q., Wei W., Peng J.H., Liu G.P., Zhou X.W., Wang Q., Wang D.W., and Wang J.Z. Homocysteine induces tau phosphorylation by inactivating protein phosphatase 2A in rat hippocampus. Neurobiol. Aging (2007)
88. Zhang C.E., Tian Q., Wei W., Peng J.H., Liu G.P., Zhou X.W., Wang Q., Wang D.W., and Wang J.Z. Homocysteine induces tau phosphorylation by inactivating protein phosphatase 2A in rat hippocampus. Neurobiol. Aging 29 (2008) 1654-1665
89. Zhang H.S., Cao E.H., and Qin J.F. Homocysteine induces cell cycle G1 arrest in endothelial cells through the PI3K/Akt/FOXO signaling pathway. Pharmacology 74 (2005) 57-64
90. Zieminska E., and Lazarewicz J.W. Excitotoxic neuronal injury in chronic homocysteine neurotoxicity studied in vitro: the role of NMDA and group I metabotropic glutamate receptors. Acta Neurobiol. Exp. (Wars) 66 (2006) 301-309
91. Zieminska E., Stafiej A., and Lazarewicz J.W. Role of group I metabotropic glutamate receptors and NMDA receptors in homocysteine-evoked acute neurodegeneration of cultured cerebellar granule neurones. Neurochem. Int. 43 (2003) 481-492